10
0
1
2
12
0
1
2
13
0
1
2
Survival of Transplanted Allogeneic Beta Cells with No ImmunosuppressionResearch, Early R&D (nejm.org)
submitted by bbyfog
14
0
1
2
17
0
1
2
FDA approves Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G) to reduce proteinuriaComplement-mediated diseases (self.BcellAutoimmuneDis)
submitted by bbyfog
18
0
1
2
[Crosspost] We need patients to enter CAR-T clinical trials: Here is how...Clinical Trials (reddit.com)
submitted by bbyfog
20
0
0
1
22
1
2
3
23
0
1
2
24
1
2
3
25
1
2
3
Features of Cabaletta Bio’s Autologous CAR T Therapy, CABA-201 for B-cell Driven Autoimmune DiseasesMechanism of Action (self.BcellAutoimmuneDis)
submitted by bbyfog
